Global Renal Denervation Systems Market Report and Forecast 2024-2032

Global Renal Denervation Systems Market Size

The global renal denervation systems market was valued at USD 626.44 million in 2023, driven by increasing incidence of hypertension across the globe. The market is expected to grow at a CAGR of 35.0% during the forecast period of 2024-2032, with the values likely to reach USD 8993.93 million by 2032.

Global Renal Denervation Systems Market Outlook

• One of the major market trends is the increase in clinical trials to develop devices or systems to cater the long-term solution for hypertension.

• The growing demand for renal denervation systems is driven by the need to combat the cardiovascular disease related mortality, which is approximately 1 in 13 people worldwide due to heart diseases.

• The European region is likely to exhibit considerable growth in the forecast period.

Global Renal Denervation Systems Market Overview

Renal denervation (RDN) systems market deals with devices that are used in renal denervation or renal ablation used to treat hypertension by disrupting nerve activity in kidneys. The procedure is minimally invasive providing patients with a safe and effective option.

According to World  Health Organization, 1.28 billion adults between the age of 30-79 years globally are affected by hypertension. In November 2023, Recor Medical announced the launch of Recor’s Paradise™ Ultrasound Renal Denervation (uRDN) system for the treatment of hypertension. This therapy was the first FDA approved renal denervation therapy in the United States, representing a breakthrough in the management of cardiovascular health.

The market is also driven by increasing preference for minimally invasive procedures due to increased awareness, technological advancements in medical science among others.

Global Renal Denervation Systems Market Growth Drivers

Increasing Prevalence of Cardiovascular Diseases to Affect the Market Landscape Significantly

The increase in prevalence of cardiovascular diseases is growing significantly resulting in the demand of technological advancements and innovations to curb the global disease burden. Globally, deaths due to cardiovascular diseases are estimated to be 17 .9 million. The renal denervation system targets the renal nerves responsible for regulating blood pressure, thereby offering an alternative to patients with resistant hypertension to the traditional drug regimens.

 
Increase in FDA Approvals to Meet Rising Renal Denervation Systems Market Demand

In November 2023, Medtronic  received FDA approval for its minimally Invasive device, Symplicity Spyral™ renal denervation (RDN) system, also known as the Symplicity™, designed for the treatment of hypertension by radiofrequency ablation. The development resulted from a series of clinical trial data supporting the safety and efficacy of the system. Medtronic’s approach to clinical development with strategic collaboration with clinical experts was a crucial part in navigating the regulatory landscape and securing the approval.

Global Renal Denervation Systems Market Trends

The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:

Global Renal Denervation Systems Market Segmentation

Market Breakup by Type

• Catheter

• Single Electrode Catheter

• Multi Electrode Catheter

• RF Generator

• Nerve Modifying Agents

Market Breakup by Product

• Simplicity

• Enlightn

• Vessix

• Paradise

• Iberis

• Others

Market Breakup by Technology

• Radiofrequency

• Ultrasound

• Micro-Infusion

Market Breakup by Application

• Hypertension

• Cardiac Disorders

• Diabetes

• Renal Failure

• Others

Market Breakup by End Use

• Diagnostic Centers and Hospitals

• Ambulatory Care Centers

• Others

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Renal Denervation Systems Market Share

Market Segmentation Based on Application Areas is Expected to Experience Substantial Growth

Based on application, the market segmentation includes hypertension, cardiac disorders, diabetes, renal failure among others. The growing burden of chronic diseases and the increasing prevalence of treatment-resistance hypertension worldwide is the primary factor driving the market growth. The renal denervation systems offer an alternative to long term medications along with decreasing the possibility of cardiovascular diseases associated with hypertension, thereby impacting the market value significantly. Renal failure and diabetes segment are also poised for considerable growth, propelled by the increasing global incidence of these conditions.

Radiofrequency Technology Is Expected to Lead the Market Share

Based on technology, the market is segmented into radiofrequency, ultrasound, and micro-infusion. Radiofrequency dominates the market, owing to its effectiveness and the widespread adoption in clinical settings. Conversely, ultrasound segment can be considered as the fastest growing due to its enhanced safety attracting clinicians and the patients along with its non-invasive nature. Altogether, technological advancements are expected to boost the renal denervation systems market growth during the forecast period with ultrasound exhibiting the most dynamic expansion.

Global Renal Denervation Systems Market Analysis by Region

The market by region is segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Europe is estimated to lead the market attributed to its adoption of technology, advanced healthcare infrastructure and strong healthcare regulatory framework with the government supporting the innovations in medical devices. Research and collaboration developments in European nations further supports the market by enhancing technological improvements and clinical outcomes.

Asia Pacific is expanding at a rapid rate and expected to exhibit fastest growth. This expansion is driven by the growing burden of lifestyle diseases like hypertension and diabetes along with renal diseases in its large group of aging population. In this region, countries like India and China have boosted the expenditure on healthcare infrastructure development. Additionally, medical treatments are becoming accessible in large group of population of these countries due to growing income levels. Increasing awareness of non-invasive technologies in treating diseases in the region is contributing to the growth of the market.

Leading Players in the Global Renal Denervation Systems Market

The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Terumo Corporation

• Johnson & Johnson Services, Inc.

• Medtronic

• Otsuka Holdings Co., Ltd

• Boston Scientific Corporation

• SympleSurgical Inc.

• Mercator MedSystems, Inc.

• Abbott

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report

Key Questions Answered in the Global Renal Denervation Systems Market Report

• What was the global renal denervation systems market value in 2023?
• What is the global renal denervation systems market forecast outlook for 2024-2032?
• What are the regional markets covered in the EMR report?
• What is market segmentation based on type?
• What is the market breakup based on product?
• Where is the major end use of the market?
• What type of technologies are present in the market?
• Where does renal denervation systems find its application?
• What are the major factors aiding the global renal denervation systems market demand? 
• How has the renal denervation systems market performed so far and how is it anticipated to perform in the coming years?
• What are the major market trends influencing the market? 
• What are the market's major drivers, opportunities, and restraints? 
• Which regional market is expected to lead the market share in the forecast period? 
• Which country is expected to experience expedited growth during the forecast period? 
• How does the prevalence and incidence of cardiovascular diseases affect the market landscape?
• What are the major global renal denervation systems market trends?
• How does the rise in the geriatric population impact the market size?
• What product will dominate the market share? 
• Which application area is expected to have a high market value in the coming years?
• Which technology type will experience the highest demand in the market segment?
• Who are the key players involved in the renal denervation systems market?
• What is patent landscape of the market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, and mergers & acquisitions among the key market players shaping the market dynamics?